172 related articles for article (PubMed ID: 37874837)
1. Host-pathogen interaction: Enterobacter cloacae exerts different adhesion and invasion capacities against different host cell types.
Frutos-Grilo E; Kreling V; Hensel A; Campoy S
PLoS One; 2023; 18(10):e0289334. PubMed ID: 37874837
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
Chang CL; Su LH; Lu CM; Tai FT; Huang YC; Chang KK
J Hosp Infect; 2013 Oct; 85(2):118-24. PubMed ID: 23954065
[TBL] [Abstract][Full Text] [Related]
3. Characterization and proteomic analysis of outer membrane vesicles from a commensal microbe, Enterobacter cloacae.
Bhar S; Edelmann MJ; Jones MK
J Proteomics; 2021 Jan; 231():103994. PubMed ID: 33007464
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of two bacterial strains co-isolated from a urinary tract infection: NDM-1-producing Enterobacter cloacae accompanied by extended-spectrum β-lactamase-producing Escherichia coli.
Xu J; He F
J Glob Antimicrob Resist; 2019 Jun; 17():198-200. PubMed ID: 31005730
[TBL] [Abstract][Full Text] [Related]
5. Isolates of the Enterobacter cloacae complex induce apoptosis of human intestinal epithelial cells.
Krzymińska S; Koczura R; Mokracka J; Puton T; Kaznowski A
Microb Pathog; 2010 Sep; 49(3):83-9. PubMed ID: 20451600
[TBL] [Abstract][Full Text] [Related]
6. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
7. Pathological and therapeutic significance of cellular invasion by Proteus mirabilis in an enterocystoplasty infection stone model.
Mathoera RB; Kok DJ; Verduin CM; Nijman RJ
Infect Immun; 2002 Dec; 70(12):7022-32. PubMed ID: 12438382
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae.
Lin KH; Chuang YC; Lee SH; Yu WL
J Microbiol Immunol Infect; 2010 Aug; 43(4):317-22. PubMed ID: 20688292
[TBL] [Abstract][Full Text] [Related]
9. Aqueous Root Extract from Ononis spinosa Exerts Anti-adhesive Activity against Uropathogenic Escherichia coli.
Deipenbrock M; Sendker J; Hensel A
Planta Med; 2020 Mar; 86(4):247-254. PubMed ID: 31968378
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
Gagnon M; Zihler Berner A; Chervet N; Chassard C; Lacroix C
J Microbiol Methods; 2013 Sep; 94(3):274-9. PubMed ID: 23835135
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of virulence-associated properties in Enterobacter cloacae.
Keller R; Pedroso MZ; Ritchmann R; Silva RM
Infect Immun; 1998 Feb; 66(2):645-9. PubMed ID: 9453621
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of colistin is resurrected by Stephania suberosa Forman extract against colistin-resistant Enterobacter cloacae.
Suknasang S; Teethaisong Y; Kabkhunthod S; Mingsiritom N; Chueakwon P; Eumkeb G
Lett Appl Microbiol; 2019 Aug; 69(2):128-135. PubMed ID: 31148182
[TBL] [Abstract][Full Text] [Related]
13. Colistin Susceptibility in Companion Animal-Derived
Sato T; Harada K; Usui M; Yokota SI; Horiuchi M
Front Cell Infect Microbiol; 2022; 12():946841. PubMed ID: 35873176
[TBL] [Abstract][Full Text] [Related]
14. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?
Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A
J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract infections caused by endemic multi-resistant Enterobacter cloacae in a dialysis and transplantation unit.
Kamińska W; Patzer J; Dzierzanowska D
J Hosp Infect; 2002 Jul; 51(3):215-20. PubMed ID: 12144801
[TBL] [Abstract][Full Text] [Related]
16. Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples.
Pereira S; Pereira C; Santos L; Klumpp J; Almeida A
Virus Res; 2016 Jan; 211():199-208. PubMed ID: 26541317
[TBL] [Abstract][Full Text] [Related]
17. Infective endocarditis by
Ioannou P; Vamvoukaki R; Kofteridis DP
J Chemother; 2022 Feb; 34(1):1-8. PubMed ID: 34369324
[No Abstract] [Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
19. soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump.
Telke AA; Olaitan AO; Morand S; Rolain JM
J Antimicrob Chemother; 2017 Oct; 72(10):2715-2721. PubMed ID: 29091215
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the type 6 secretion system (T6SS) of E. cloacae SBP-8 and its role in pathogenesis and bacterial competition.
Khan S; Marathe SA; Jha PN
Microb Pathog; 2023 Oct; 183():106268. PubMed ID: 37536636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
